115450 Stock Chart & Stats
₩1657.00
₩137.00(9.01%)
―
--
Day’s Range― - ―
52-Week Range₩1,342.00 - ₩4,160.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)571.52K
Market Cap
₩146.11B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding88,580,110
10 Day Avg. Volume1,065,654
30 Day Avg. Volume571,517
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,741,312.44
Revenue Forecast (FY)₩10.00T>
115450 FAQ
What was HLB Therapeutics Co., Ltd.’s price range in the past 12 months?
HLB Therapeutics Co., Ltd. lowest stock price was ₩1342.00 and its highest was ₩4160.00 in the past 12 months.
What is HLB Therapeutics Co., Ltd.’s market cap?
HLB Therapeutics Co., Ltd.’s market cap is ₩146.11B.
When is HLB Therapeutics Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HLB Therapeutics Co., Ltd.’s earnings last quarter?
HLB Therapeutics Co., Ltd. released its earnings results on May 15, 2026. The company reported -₩49 earnings per share for the quarter, missing the consensus estimate of N/A by -₩49.
Is HLB Therapeutics Co., Ltd. overvalued?
According to Wall Street analysts HLB Therapeutics Co., Ltd.’s price is currently Undervalued.
Does HLB Therapeutics Co., Ltd. pay dividends?
HLB Therapeutics Co., Ltd. does not currently pay dividends.
What is HLB Therapeutics Co., Ltd.’s EPS estimate?
HLB Therapeutics Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HLB Therapeutics Co., Ltd. have?
HLB Therapeutics Co., Ltd. has 88,580,110 shares outstanding.
What happened to HLB Therapeutics Co., Ltd.’s price movement after its last earnings report?
HLB Therapeutics Co., Ltd. reported an EPS of -₩49 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.983%.
Which hedge fund is a major shareholder of HLB Therapeutics Co., Ltd.?
Currently, no hedge funds are holding shares in KR:115450
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kanaph Therapeutics Inc.
―
VIVOZON PHARMACEUTICAL CO., LTD.
―
Jeil Pharmaceutical Co. Ltd.
―
Hana Pharm Co., Ltd.
―
Prestige Biologics Co., Ltd.
―